Endoscopic colorectal cancer screening: A cost-saving analysis

Journal of the National Cancer Institute

Volumn 92, Issue 7, 2000, Pages 557-563

  Loeve, Franka ^b   Brown, Martin L ^a   Boer, Rob ^c   Van Ballegooijen, Marjolein ^c   Van Oortmarssen, Gerritt J ^c   Habbema, J Dik F ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; COST CONTROL; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HUMAN; MODEL; PRIORITY JOURNAL; SIGMOIDOSCOPY; UNITED STATES;

EID: 0034607255     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.7.557     Document Type: Article

References (55)

1. de Koning HJ, van Ineveld BM, van Oortmarssen GJ, de Haes JC, Collette HJ, Hendriks JH, et al. Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors, Int J Cancer 1991;49:531-7.
2. van Ballegooijen M, Boer R, van Oortmarssen GJ, Koopmanschap MA, Lubbe JT, Habbema JD. Cervical cancer screening: age-ranges and intervals. An updated cost-effectiveness analysis. Rotterdam (The Netherlands): Erasmus University; 1993.
3. Brown ML, Fintor L. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat 1993;25:113-8.
4. Ries LA, Kosary CL, Hankey BF, Miller BA, Edwards BK. SEER cancer statistics review, 1973-1995. Bethesda (MD): National Cancer Institute: 1998.
5. Markowitz AJ, Winawer SJ. Screening and surveillance for colorectal carcinoma. Hematol Oncol Clin North Am 1997;11:579-608.
6. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
7. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328: 1365-71.
8. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
9. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
10. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
11. Whynes DK, Neilson AR, Walker AR, Hard-castle JD. Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ 1998;7:21-9.
12. Gyrd-Hansen D, Sogaard J, Kronborg O, Colorectal cancer screening: efficiency and effectiveness. Health Econ 1998;7:9-20.
13. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press; 1996.
14. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
15. Selby JV. Clinical trials of screening sigmoidoscopy. In: Cohen AM, Winawer SJ, editors. Cancer of the colon, rectum, and anus. New York (NY): McGraw-Hill; 1995. p. 291-302.
16. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer. A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
17. Hoff G, Sauar J, Vatn MH, Larsen S, Langmark F, Moen IE, et al. Polypectomy of adenomas in the prevention of colorectal cancer: 10 years' follow-up of the Telemark Polyp Study I. A prospective, controlled population study. Scand J Gastroenterol 1996;31:1006-10.
18. Rex D. Barium enema and colon cancer screening: finally a study. Am J Gastroenterol 1997;92:1570-2.
19. Berry DP, Clarke P, Hardcastle JD, Vellacott KD. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg 1997;84:1274-6.
20. Brevinge H, Lindholm E, Buntzen S, Kewenter J. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 55-56 years' old population. Int J Colorectal Dis 1997;12: 291-5.
21. Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J. et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998;42: 560-5.
22. Loeve F, Boer R, van Oortmarssen GJ, van Ballegooijen M, Habbema JD. The MISCAN-COLON simulation model for the evaluation of colorectal cancer screening. Comput Biomed Res 1999;32:13-33.
23. Habbema JD, van Oortmarssen GJ, Lubbe JT, van der Maas PJ. The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed 1984;20:79-93.
24. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PM. van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 1995;87: 1217-23.
25. Koopmanschap M, Lubbe JT, van Oortmarssen GJ, van Agt HM, van Ballegooijen M, Habbema JD. Economic aspects of cervical cancer screening. Soc Sci Med 1990;30: 1081-7.
26. van Ballegooijen M, van den Akker-van Marie ME, Warmerdam PG. Meijer CJ, Walboomers JM, Habbema JD. Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness. Br J Cancer 1997;76: 651-7.
27. Surveillance, Epidemiology, and End Results (SEER) Program public use CD-ROM (1973-1994): Bethesda (MD): National Cancer Institute, Division of Cancer Prevention and Control, Surveillance Program, Cancer Statistics Branch, released May 1997, based on the August 1996 submission.
28. Johnson DA, Gurney MS, Volpe RJ, Jones DM, van Ness MM, Chobanian SJ, et al. A prospective study of the prevalence of colonie neoplasms in asymptomatic patients with agerelated risk. Am J Gastraenterol 1990;85: 969-74.
29. DiSario JA, Foutch PG, Mai HD, Pardy K, Manne RK. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991;86:941-5.
30. Liebernian DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-51.
31. Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith JJ. Screening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterology 1991;100:593-5.
32. Koretz, RL. Malignant polyps: are they sheep in wolves' clothing? Ann Intern Med 1993; 118:63-8.
33. Beahrs AH, Henson DE, Hutter RV, Myers MH. Manual for staging of cancer. Philadelphia (PA): Lippincott; 1988.
34. Gyrd-Hansen D, Sogaard J, Kronborg O. Analysis of screening data: colorectal cancer. Int J Epidemiol 1997;26:1172-81.
35. Launoy G, Smith TC. Duffy SW, Bouvier V. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer 1997;73:220-4.
36. Palitz AM, Selby JV, Grossman S, Finkler LJ, Bevc M, Kehr C, et al. The Colon Cancer Prevention Program (CoCaP): rationale, implementation, and preliminary results. HMO Pract 1997;11:5-12. [Au: confirm ref]
37. Williams AR, Balasooriya BA, Day DW. Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut 1982;23:835-42.
38. Levin TR, Palitz A, Grossman S, Conell C, Finkler L, Ackerson L, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA 1999;281: 1611-7.
39. Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS. Prospective blinded trial of the colonoscopic miss-rate of large colorectal polyps. Gastrointest Endosc 1991;37:125-7.
40. Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper D, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997; 112:24-8.
41. Wagner JL, Tunis S, Brown M, Ching A, Almeida R. Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B, editors. Prevention and early detection of colorectal cancer. London (U.K.): Saunders; 1996. p. 321-56.
42. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: does reimbursement cover costs? Ann Intern Med 1999; 130: 525-30.
43. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-90.
44. Rogge JD, Elmore MF, Mahoney SJ, Brown ED, Troiano FP, Wagner DR, et al. Low-cost, office-based, screening colonoscopy. Am J Gastroenterol 1994;89:1775-80.
45. Neugut AI, Young GP. Screening for colorectal cancer: an overview. In: Young GP, Rozen P, Levin B, editors. Prevention and early detection of colorectal cancer. London (U.K.): Saunders; 1996. p. 357-67.
46. Lieberman D. Mass screening: North American perspective. In: Young GP, Rozen P, Levin B, editors. Prevention and early detection of colorectal cancer. London (U.K.): Saunders; 1996. p. 289-300.
47. Fireman BH, Quesenberry CP, Somkin CP, Jacobsun AS, Baer D, West D, et al. Cost of care for cancer in a health maintenance organization. Health Care Financ Rev 1997;18: 51-76.
48. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-8.
49. Senore C, Segnan N, Rossini FP, Ferraris R, Cavallero M, Coppola F, et al. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen 1996;3:72-8.
50. Winawer SJ, Zauber AG, O'Brien MJ, Ho MN, Gottlieb L, Sternberg SS, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med 1993;328: 901-6.
51. Winawer SJ, Zauber AG, Ho MH. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
52. Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute. J Urol 1994;152(5 Pt 2): 1905-9.
53. DiSario JA, Sanowski RA. Sigmoidoscopy training for nurses and resident physicians. Gastrointest Endosc 1993;39:29-32.
54. Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990;113:373-84.
55. Click S, Wagner JL, Johnson CD. Cost-effectiveness of double-contrast barium enema in screening for colorectal cancer. Am J Roentgenol 1998;170:629-36.